Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk (HIP)
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Lifestyle interventions to lower blood pressure for patients
MD CQI-type intervention
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Behavioral intervention, Lifestyle modification, Guidelines
Eligibility Criteria
Inclusion Criteria: Receiving primary care from participating physicians from practices in the Duke Primary Care Research Consortium Hypertension Exclusion Criteria: Primary care doctor advises against enrollment Pregnant, nursing, or planning pregnancy Recent CVD event Chronic kidney or liver disease Active cancer
Sites / Locations
- Duke University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Experimental
Experimental
Experimental
Arm Label
MD-C/PT-C
MD-I/PT-C
MD-C/Pt-I
MD-I/Pt-I
Arm Description
Physician and patient control group.
MD CQI-type intervention; Patient control
MD control; patient behavioral intervention
MD CQI-type intervention; Patient behavioral intervention
Outcomes
Primary Outcome Measures
Change in systolic blood pressure
Secondary Outcome Measures
Change in diastolic BP
Change in BP at 18 months
Patient and MD adherence to intervention
Full Information
NCT ID
NCT00201136
First Posted
September 12, 2005
Last Updated
October 11, 2015
Sponsor
Duke University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
1. Study Identification
Unique Protocol Identification Number
NCT00201136
Brief Title
Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk
Acronym
HIP
Official Title
Hypertension Improvement Project (HIP)
Study Type
Interventional
2. Study Status
Record Verification Date
February 2012
Overall Recruitment Status
Completed
Study Start Date
February 2004 (undefined)
Primary Completion Date
August 2008 (Actual)
Study Completion Date
August 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will test the separate and combined effects of a continuous quality improvement (CQI) intervention for physicians (MDs) and a behavioral intervention for patients on blood pressure control.
Detailed Description
BACKGROUND:
Hypertension affects 25% of adults in the United States and remains a leading cause of heart disease, stroke, and kidney failure. Despite numerous effective treatments, only 25% of people with hypertension are at goal blood pressure (BP). The chronic care model suggests that BP control can be achieved by improving patient self-care and the systems through which care is delivered. Patient self-care efforts should be directed at counteracting the effects of obesity, physical inactivity, poor dietary pattern, and non-adherence to prescribed medications on BP. In addition, efforts should be directed at the use of quality improvement systems that can counteract the well-documented non-adherence of primary care MDs to established clinical practice guidelines. In addition to improving BP control, these approaches can also reduce costs associated with hypertension and its consequences. However, given the resources that would be required to implement such approaches, it is critical that their effectiveness be rigorously established. This controlled study will test the separate and combined effects of a behavioral intervention for patients and a CQI intervention for MDs on BP control. The patient intervention will employ proven behavioral methods for promoting a healthy lifestyle and adherence to medication regimens. The MD intervention will use a CQI approach to provide training, motivation, and feedback on performance in a non-threatening way to promote continuous self-improvement and adherence to clinical practice guidelines.
DESIGN NARRATIVE:
The Hypertension Improvement Project (HIP) is a randomized, controlled study that will test the separate and combined effects of a CQI intervention for MDs and a behavioral intervention for patients on BP control. MDs will be selected from practices in the Duke Primary Care Research Consortium that serve low-income and minority populations. Practices will be randomly assigned to the MD intervention or to the MD control condition. Within these practices, all MDs will receive the same intervention and their patients will be individually randomized to the patient intervention or to the patient usual care condition. The MD intervention consists of the following three main elements: 1) on-line training modules; 2) an evaluation and treatment algorithm for use in the clinic; and 3) a CQI procedure involving assessment of clinical performance measures and feedback to MDs on their adherence to guidelines. The performance data will be collected for 18 months and feedback will be provided to MDs every 3 months. Patients from these practices (approximately 50% women, at least 40% African American, and 90% low-income) will be randomly assigned to patient intervention or usual care. The patient intervention consists of a 6-month behavioral intervention aimed at lifestyle changes to lower BP and promote adherence to prescribed BP medications. BP and other follow-up measurements will be performed at the end of the intervention and a year later (at 6 and 18 months post-randomization). The primary outcome will be the proportion of patients in each treatment group that have adequate BP control at 6 months. BP control is defined by the Joint National Committee 6 (JNC-6) goals (systolic BP less than 140 mm Hg and diastolic BP less than 90 mm Hg for most patients; lower goals for patients with cardiovascular or renal disease, or diabetes). Other outcomes of this study will include BP control at 18 months, MD adherence to national guidelines, and patient adherence to lifestyle recommendations and medication regimens. A cost analysis will also be done. The study will enroll 500 patients in 10 practices (approximately 20 MDs), and will have 80% power to detect an effect size of 0.3 for the primary outcome. The HIP study will test practical interventions for improving hypertension control that can be broadly implemented and can reduce CVD risk.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Behavioral intervention, Lifestyle modification, Guidelines
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
574 (Actual)
8. Arms, Groups, and Interventions
Arm Title
MD-C/PT-C
Arm Type
No Intervention
Arm Description
Physician and patient control group.
Arm Title
MD-I/PT-C
Arm Type
Experimental
Arm Description
MD CQI-type intervention; Patient control
Arm Title
MD-C/Pt-I
Arm Type
Experimental
Arm Description
MD control; patient behavioral intervention
Arm Title
MD-I/Pt-I
Arm Type
Experimental
Arm Description
MD CQI-type intervention; Patient behavioral intervention
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle interventions to lower blood pressure for patients
Intervention Description
Weight loss, DASH dietary pattern, increased physical activity, reduced salt intake, moderation of alchohol intake.
Intervention Type
Behavioral
Intervention Name(s)
MD CQI-type intervention
Intervention Description
CQI-type intervention for MD adherence to JNC guidelines for BP management
Primary Outcome Measure Information:
Title
Change in systolic blood pressure
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in diastolic BP
Time Frame
6 months
Title
Change in BP at 18 months
Time Frame
18 months
Title
Patient and MD adherence to intervention
Time Frame
6 and 18 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Receiving primary care from participating physicians from practices in the Duke Primary Care Research Consortium
Hypertension
Exclusion Criteria:
Primary care doctor advises against enrollment
Pregnant, nursing, or planning pregnancy
Recent CVD event
Chronic kidney or liver disease
Active cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura P. Svetkey
Organizational Affiliation
Duke University
Official's Role
Study Chair
Facility Information:
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
19920081
Citation
Svetkey LP, Pollak KI, Yancy WS Jr, Dolor RJ, Batch BC, Samsa G, Matchar DB, Lin PH. Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension. 2009 Dec;54(6):1226-33. doi: 10.1161/HYPERTENSIONAHA.109.134874.
Results Reference
derived
PubMed Identifier
19245692
Citation
Dolor RJ, Yancy WS Jr, Owen WF, Matchar DB, Samsa GP, Pollak KI, Lin PH, Ard JD, Prempeh M, McGuire HL, Batch BC, Fan W, Svetkey LP. Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials. 2009 Feb 26;10:13. doi: 10.1186/1745-6215-10-13.
Results Reference
derived
Learn more about this trial
Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk
We'll reach out to this number within 24 hrs